[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351738-105":59,"doc-detail-351738-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","eno1-as-a-central-regulator-linking-metabolic-reprogramming-to-tumor-plasticity","ENO1 as a Central Regulator Linking Metabolic Reprogramming to Tumor Plasticity","","Alpha-enolase (ENO1) is a multifunctional glycolysis protein with expanding evidence for roles in cancer development and progression. This review synthesizes biological and clinical findings on ENO1 across multiple cancer types, including physiological characteristics, tissue distribution, aberrant expression, and genomic alterations. It evaluates ENO1-linked mechanisms spanning proliferation, apoptosis resistance, stemness, autophagy, metastasis, drug resistance, and angiogenesis, and summarizes prognostic correlations from pan-cancer and individual datasets. Overall, ENO1 supports malignant progression via metabolic reprogramming and tumor-promoting cellular functions, suggesting biomarker and therapeutic potential pending further validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/eno1-as-a-central-regulator-linking-metabolic-reprogramming-to-tumor-plasticity/351738/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/eno1-as-a-central-regulator-linking-metabolic-reprogramming-to-tumor-plasticity/351738.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological role does ENO1 have in normal physiology?","Question",{"text":112,"@type":113},"ENO1 (alpha-enolase) catalyzes a key glycolysis step converting 2-phosphoglycerate to phosphoenolpyruvate, influencing carbon flux toward ATP and biosynthetic intermediates.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does this review connect ENO1 to tumor plasticity and progression?",{"text":117,"@type":113},"The review links ENO1 to multiple tumor-promoting processes, including metabolic reprogramming, proliferation, apoptosis resistance, stemness, autophagy, metastasis, drug resistance, and angiogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of evidence are summarized regarding ENO1 in cancer?",{"text":121,"@type":113},"It summarizes normal tissue distribution, aberrant expression and genomic alterations in cancers, mechanistic studies of ENO1-associated cellular functions, and associations between ENO1 expression and patient prognosis in pan-cancer datasets and individual malignancies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351738,1790218419,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Review  \nENO1 as a Central Regulator Linking Metabolic Reprogramming to Tumor Plasticity  \nTsung-Chieh Lin 1,2  \nAcademic Editor: Atsushi Matsuzawa  \nReceived: 18 April 2026  \nRevised: 13 May 2026  \nAccepted: 14 May 2026  \nPublished: 16 May 2026  \nCopyright: © 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Genomic Medicine Core Laboratory, Department of Medical Research and Development, Chang Gung Memorial Hospital, Linkou, Taoyuan City 333, Taiwan; [tclin1980@cgmh.org.tw](tclin1980@cgmh.org.tw);  \nTel.: +886-3-3281200 (ext. 7722)  \n2 Department of Biomedical Sciences, Chang Gung University, Taoyuan City 333, Taiwan  \nAbstract  \nAlpha-enolase (ENO1) is a multifunctional protein best known for its canonical role in glycolysis, but growing evidence indicates that it also plays important roles in cancer development and progression. This review summarizes the current knowledge regarding the biological and clinical significance of ENO1 across multiple cancer types. We first outline the physiological characteristics of ENO1 and its distribution in normal tissues. Then, we discuss its aberrant expression patterns and genomic alterations in human cancers. We further examine the evidence linking ENO1 to major cancer-related processes, including proliferation, apoptosis resistance, cancer stemness, autophagy, metastasis, drug resistance, and angiogenesis. In addition, we review studies that evaluate the association between ENO1 expression and patient prognosis in pan-cancer datasets and individual malignancies. Collectively, the available literature indicates that ENO1 is closely associated with malignant progression through its involvement in metabolic reprogramming and broader tumor-promoting cellular functions. These findings suggest that ENO1 may serve as a context-dependent biomarker and a candidate therapeutic target in selected cancer settings; however, further mechanistic validation and clinically annotated studies are required before its translational value can be firmly established.  \nKeywords: ENO1; cancer metabolism; tumor progression; metastasis; drug resistance; prognostic biomarker; pan-cancer analysis  \n1. Introduction  \nENO1 (alpha-enolase) is encoded by the ENO1 gene and catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis, making it a central determinant of carbon flux toward ATP and biosynthetic intermediates [1] . The ENO1 gene is located at 1p36.23 in humans and encodes various isoforms, with a total of 15 transcript variants (Figure 1) . The alternative translation of the ENO1 gene may lead to the synthesis of a shorter protein variant called the c-MYC promoter-binding protein (MBP-1) that acts asa transcription repressor for the c-MYC oncogene [2] . ENO1 is best known for its role in modulating glycolysis and embryonic stem cell differentiation [3] .  \nRecent studies have highlighted a broader role for ENO1 in tumorigenesis and cancer progression. In a study of chronic hepatitis B virus (HBV) infection-associated hepatocellular carcinoma cells, ENO1 overexpression causes malignant behaviors in cancer, and this increased expression is induced by the hepatitis B virus X protein (Hbx) [4] . In a study addressing the role of long non-coding RNA LINC00183 in colorectal cancer proliferation  \nand invasiveness, the LINC00183–enolase 1 interaction was uncovered, leading to the activation of glycolysis, lactate accumulation, and upregulation of the oncogene GDF15 [5] . Enolase 1 could directly bind and stabilize BACE2 from lysosomal-dependent degradation to remodel cholesterol metabolism, thereby promoting liver cancer progression [6] . Growing experimental evidence indicates that ENO1 and its downstream signaling network contribute to multiple malignant phenotypes, including angiogenesis, metastasis, proliferation, cancer stemness, and drug resis","cbCain9Jv27qfddE","https://ap.wps.com/l/cbCain9Jv27qfddE","pdf",4072833,17,"English","# Abstract\n# 1. Introduction\n# 2. ENO1 Somatic Mutation and Cancer","[{\"question\":\"What biological role does ENO1 have in normal physiology?\",\"answer\":\"ENO1 (alpha-enolase) catalyzes a key glycolysis step converting 2-phosphoglycerate to phosphoenolpyruvate, influencing carbon flux toward ATP and biosynthetic intermediates.\"},{\"question\":\"How does this review connect ENO1 to tumor plasticity and progression?\",\"answer\":\"The review links ENO1 to multiple tumor-promoting processes, including metabolic reprogramming, proliferation, apoptosis resistance, stemness, autophagy, metastasis, drug resistance, and angiogenesis.\"},{\"question\":\"What types of evidence are summarized regarding ENO1 in cancer?\",\"answer\":\"It summarizes normal tissue distribution, aberrant expression and genomic alterations in cancers, mechanistic studies of ENO1-associated cellular functions, and associations between ENO1 expression and patient prognosis in pan-cancer datasets and individual malignancies.\"}]","ENO1 as a Central Regulator Linking Metabolic Reprogramming to Tumor Plasticity | PDF",1790095591,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b124f6c01d92657f639a1aaeea2a97bc.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07b66859209efaa92e2966b24f7f83ef.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0387347b5e81b5b7a301335e054cf769.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0197a7afcefb84d5ab57d2b71f51b84b.webp",980,1385]